Status:

ACTIVE_NOT_RECRUITING

Improving Sleep and AD Biomarkers

Lead Sponsor:

Emory University

Collaborating Sponsors:

National Institute on Aging (NIA)

Conditions:

Mild Cognitive Impairment

Alzheimer Disease

Eligibility:

All Genders

60+ years

Phase:

NA

Brief Summary

The purpose of this research is to learn whether a dietary citicoline supplement will impact sleep and cognition. Cognitive disorders include such things as memory disorders and mild cognitive impairm...

Detailed Description

This is a randomized double-blind placebo-controlled pilot trial. To assess the hypothesis in this proposed study, the investigator will leverage infrastructure from the Emory Alzheimer's disease rese...

Eligibility Criteria

Inclusion

  • Age: 60 years or older
  • Diagnosis of Mild Cognitive Impairment (MCI)
  • Pittsburgh Sleep Quality Index total score \>5 or Epworth Sleepiness Scale score of ≥ 10
  • Read and understand English
  • Have Internet and email access

Exclusion

  • No telephone access
  • Must not be taking any medication known to affect rapid eye movement (REM) sleep (or sleep architecture in general)
  • Use of choline supplements.
  • Epilepsy or head trauma resulting in unconsciousness in the past two years
  • Known allergic reactions to components of Citicoline
  • Presence of chronic obstructive pulmonary disease, asthma, severe cardiac insufficiency (congestive heart failure, myocardial infarction), type I diabetes, vitamin B12 or folic acid deficiency, liver cirrhosis, thyroid dysfunction, rheumatoid arthritis, chronic renal failure, severe/unstable psychiatric disorders, moderate to severe obstructive sleep apnea, restless legs syndrome or periodic limb movement disorder
  • History of alcohol dependence and drug abuse
  • Night shift workers or those in situations where they regularly experience jet lag or have irregular work schedules

Key Trial Info

Start Date :

December 15 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2026

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06029894

Start Date

December 15 2023

End Date

January 1 2026

Last Update

September 26 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Emory University School of Nursing

Atlanta, Georgia, United States, 30322

2

Goizueta Alzheimer's Disease Research Center

Atlanta, Georgia, United States, 30329